Drawing on his experience of flood risk engineering, Hossein Gheovasi makes the case for early, accurate hydrology in solar ...

b RAS G12, G13 or Q61 mut or no RAS mut identified. This is an ASCO Meeting Abstract from the 2026 ASCO Annual Meeting II. This abstract does not include a full text component.

This year’s meeting of the American Society of Clinical Oncology is abuzz with talk of RAS inhibitors, largely driven by Revolution Medicines’ barnburner pancreatic cancer data drop earlier this year.

Current therapies offer limited benefit for patients with previously treated metastatic pancreatic ductal adenocarcinoma (mPDAC). Aberrant activation of the RAS pathway is the key driver of PDAC, with ...

After dropping headline-grabbing phase 3 data for its pancreatic cancer candidate daraxonrasib last week, Revolution Medicines is not resting on its laurels. The Bay Area biotech has spent several ...

Qatar has said Iranian missile attacks on the Ras Laffan Industrial City, the country’s main gas facility, have caused “significant damage”. “The State of Qatar expresses its strong condemnation and ...

About 4,000 workers will lose their jobs as the payments company does more work with new artificial intelligence tools, its top executive said. By Natallie Rocha Reporting from San Francisco Block, ...

Block, the company behind Square, Cash App and Afterpay, is cutting its staff by 40%. The reason: “intelligence tools,” according to a letter to shareholders by co-founder Jack Dorsey. Dorsey thinks ...

WAUKEE – Chicago Cubs minor-league pitcher Tyler Ras stands to the side of the indoor baseball field at SportsPlex West on a January evening, tossing balls to high school players on the club team, the ...

Kelly Anne has over six years of experience with reporting and editing in the personal finance space. Her work has been featured in national publications including Reader's Digest, CNBC and Forbes.

The MarketWatch News Department was not involved in the creation of this content. -- Chemoproteomics screening platform identified novel covalent inhibitors that specifically disrupt RAS-mediated ...

Vividion Therapeutics, Inc. (Vividion), a clinical-stage biopharmaceutical company, and a wholly owned and independently operated subsidiary of Bayer AG, today announced the publication of a ...